Fibromuscular Dysplasia and Developmental Renal/Aortic Disorders

47.1FMD is a systemic arteriopathy

Fibromuscular dysplasia should be taught first as a systemic arteriopathy, not as an isolated renal-artery stenosis. Contemporary consensus documents frame FMD around pathology, presentation, diagnosis, management, and unanswered questions; the practical consequence for surgeons is that a patient referred for renal FMD may also have clinically relevant cervicocephalic, visceral, renal, or aneurysmal disease elsewhere. The first operation-like decision is therefore not “angioplasty or no angioplasty,” but whether the surgeon has adequately defined the patient’s arterial phenotype before committing to treatment. Gornik FMD International 2019 · Olin AHA FMD 2014 · Persu European FMD 2014

Registry and cohort data are the backbone of FMD bedside reasoning. The US FMD Registry, which enrolled the first 447 patients across centers, remains a canonical contemporary cohort reference point for presentation patterns, vascular-bed involvement, and demographics. It supports the trainee’s habit of asking, at the first consultation, whether the patient has symptoms referable to more than one vascular territory rather than treating the imaged renal lesion as the whole disease. Olin US FMD 2012

Aneurysm risk is central to the systemic framing. Adults with confirmed FMD have a higher prevalence of arterial aneurysms, including intracranial, renal, and visceral aneurysms, than the general population. That fact supports structured baseline surveillance and re-imaging when symptoms change; however, the exact surveillance interval is not defined by randomized evidence and should not be presented as a universal rule. Prevalence Intracranial Aneurysm 2017

Cerebrovascular disease is not an incidental sidebar. Multicenter cohort data link FMD with cervical and intracranial arterial dissection at rates higher than expected for the general population, and FMD is enriched among patients presenting with spontaneous cervical artery dissection. For the vascular surgeon, this means new neurologic symptoms in an FMD patient should trigger prompt cerebrovascular imaging logic, and a patient referred after spontaneous cervical or intracranial dissection deserves deliberate assessment for FMD rather than a narrow dissection-only label. Fibromuscular Dysplasia Cerebrovascular 2026 · Fibromuscular Dysplasia Spontaneous 2025 · Cerebrovascular Fibromuscular Dysplasia 2023

FMD also intersects with spontaneous coronary artery dissection. The shared pathobiology and women-predominant epidemiology of SCAD and FMD provide a useful framework for history taking and vascular-bed screening, while cervical CTA cohort imaging in SCAD populations demonstrates that cervical artery abnormalities, including FMD findings and dissections, are clinically relevant in this association. Prevalence Cervical Artery 2021 In practice, a history of SCAD should make the surgeon more alert to cervicocephalic and systemic arteriopathy, not merely to coronary follow-up. Spontaneous Coronary Artery 2020

The genetic lesson is equally practical: FMD is not managed as a single-gene syndrome in routine vascular practice. The original GWAS identified PHACTR1 as the first genome-wide-significant susceptibility locus, and later large-scale genetic work found risk loci overlapping with other cardiovascular traits, supporting FMD as a complex polygenic systemic arteriopathy. Current progress clinical 2022 · Genetic investigation fibromuscular 2021 · PHACTR1 Is Genetic 2016 A phenotype-research cohort also examined connective-tissue-disease physical features in FMD patients, reminding surgeons to consider overlapping phenotypes and risk stratification without overcalling a monogenic connective-tissue diagnosis from FMD alone. Systemic connective tissue 2015

47.2Map anatomy before intervention

Imaging strategy in FMD is a clinical decision about anatomy, risk, and the likely next action. Duplex ultrasound avoids contrast and radiation but is operator-dependent; CTA offers high spatial resolution with ionizing radiation; MRA avoids radiation but may have lower spatial resolution for distal branches. Imaging studies pediatric 2018 Most FMD programs reserve catheter angiography for cases in which intervention is planned, because diagnostic certainty alone rarely justifies an invasive angiogram when high-quality noninvasive imaging can answer the immediate question.

The imaging report must distinguish multifocal from focal disease. Classic multifocal FMD produces the angiographic “string of beads” pattern from alternating fibrous thickening and dilation, whereas focal FMD appears as a single short-segment narrowing. This distinction matters because the lesion type affects expected blood-pressure response after renal angioplasty and should be included in pre-procedure counseling. Renal artery fibromuscular 2013 · Percutaneous transluminal angioplasty 2008

For suspected renovascular hypertension, imaging should be selected with the clinical scenario in mind rather than by local habit alone. Society imaging-appropriateness guidance for renovascular hypertension provides an external framework for choosing among available modalities in a presentation that overlaps with renal FMD. The surgeon should ask whether the test will define the renal artery lesion, assess branch involvement sufficiently for treatment planning, and identify additional arterial findings that would change management. ACR Appropriateness Criteria 2026 · Imaging studies pediatric 2018

Mapping must also account for developmental renal and aortic disorders. A subset of midaortic syndrome cases has pathologic or imaging features overlapping with FMD, supporting a spectrum view of developmental aortic stenoses rather than a clean separation between “FMD” and “congenital” disease. MIDDLE AORTIC SYNDROME. 1963 When the aorta, renal arteries, and visceral branches are involved together, the trainee should resist forcing the case into a single adult renal-FMD algorithm; staged reconstruction, branch preservation, and long-term reintervention risk enter the planning discussion. Feasibility Early Midterm 2025

Pediatric and young-patient presentations require particular imaging discipline. Contemporary pediatric renovascular hypertension and midaortic syndrome cohorts emphasize long-term outcomes after angioplasty or surgical management, including restenosis, blood-pressure control, and cerebrovascular comorbidity. In children, the decision to image is not simply a one-time diagnostic step; it becomes part of a longitudinal plan that balances anatomic definition, radiation minimization, and expected need for repeated assessment. Kim Pediatric MAS 2021 · Imaging studies pediatric 2018 · Chung Pediatric Renovascular 2017

In congenital supravalvular aortic stenosis, long-horizon registry data also matter for developmental vascular thinking. A multicenter US Pediatric Cardiac Care Consortium analysis of 333 children undergoing congenital SVAS repair, with Williams-Beuren syndrome subgroup outcomes and median 25-year follow-up through National Death Index matching, reinforces that developmental arteriopathies require durable surveillance logic beyond the index repair. Long-term Outcomes After 2024 For vascular trainees, the shared lesson across SVAS, midaortic syndrome, and renovascular disease is to plan the next decade, not only the next procedure.

47.3Renal FMD intervention logic

Renal FMD intervention begins with the clinical problem, not the angiographic appearance alone. The main teachable indication is renovascular hypertension in a patient whose anatomy and clinical course make the renal lesion a plausible driver of blood pressure. The surgeon should integrate lesion pattern, patient age, hypertension duration, medication burden, and the likelihood that angioplasty will produce meaningful blood-pressure improvement rather than treating every beaded artery as an automatic target. Gornik FMD International 2019 · Olin AHA FMD 2014 · Percutaneous transluminal angioplasty 2008

Balloon angioplasty is the central renal FMD procedure in the supplied evidence base, and expectations must be lesion-specific. Observational data in adults undergoing percutaneous transluminal renal angioplasty show higher blood-pressure cure rates for focal FMD than for multifocal FMD, partly reflecting younger age at diagnosis and shorter hypertension duration. Percutaneous transluminal angioplasty 2008 This should be stated clearly before treatment: angioplasty may improve control, but “cure” is more likely in selected focal lesions than in long-standing multifocal disease. Renal artery fibromuscular 2013

Pre-intervention imaging should answer whether the anatomy is suitable for the intended treatment. Duplex, CTA, and MRA each have tradeoffs, and catheter angiography is generally best used when the operator is prepared to treat. Imaging studies pediatric 2018 A trainee should be able to explain why the chosen modality can define the target lesion, why additional vascular-bed imaging is or is not needed before intervention, and what finding would make the planned angioplasty inappropriate or insufficient. ACR Appropriateness Criteria 2026

Developmental aortic and renal disorders require a different intervention mindset from isolated adult renal FMD. Midaortic syndrome may involve the aorta and renal or visceral branches, and contemporary series report feasible and durable staged open and endovascular reconstructions in carefully selected patients, with reintervention rates that reflect the developmental nature of the disease. Feasibility Early Midterm 2025 In adult midaortic syndrome, a 14-year single-center cohort comparing open and endovascular treatment in 41 patients supplies adult-specific outcome substrate; in children, surgical and angioplasty cohorts emphasize restenosis, blood-pressure control, and associated cerebrovascular disease. Long-term outcomes surgical 2024 · Kim Pediatric MAS 2021 · Chung Pediatric Renovascular 2017

The failure modes should be discussed before the first procedure. For renal FMD, the common disappointment is incomplete blood-pressure cure despite technically successful angioplasty, especially when disease is multifocal or hypertension is long-standing. For midaortic and pediatric renovascular disease, the expected hazards include restenosis, staged-procedure needs, and later reintervention, so the operative plan should preserve future options rather than consume them. Feasibility Early Midterm 2025 · Chung Pediatric Renovascular 2017 · Percutaneous transluminal angioplasty 2008

47.4Clinical integration, follow-up, and evidence boundaries

Long-term FMD management is built around surveillance, symptom-triggered re-evaluation, and risk reduction rather than a single curative procedure. Baseline assessment for aneurysms is justified by the increased prevalence of intracranial, renal, and visceral aneurysms in confirmed FMD, while re-imaging is especially important when new symptoms suggest dissection, aneurysm change, or a newly involved vascular bed. Surveillance intervals remain registry-based rather than firmly guideline-defined, so follow-up plans should be individualized and documented with the uncertainty made explicit. Gornik FMD International 2019 · Prevalence Intracranial Aneurysm 2017

Antiplatelet therapy is commonly used in long-term FMD management for patients without bleeding contraindications, with the intent of lowering dissection and ischemic-event risk. The caveat is important: this practice is grounded in registry-level evidence and expert consensus rather than large randomized trials. For trainees, the right teaching point is not that every patient receives the same drug forever, but that bleeding risk, prior dissection or ischemic events, aneurysm status, and procedural plans should be reviewed before committing to therapy. Evidence routine brain-to-pelvis 2024

Follow-up after renal angioplasty should judge clinical and anatomic response separately. Blood-pressure response is the patient-centered endpoint, and focal lesions have higher observed cure rates than multifocal lesions; however, restenosis and incomplete blood-pressure control remain important in renovascular hypertension cohorts, particularly in pediatric and developmental disease. A technically improved renal artery should not be mistaken for a completed clinical course if medication burden, blood pressure, or symptoms remain problematic. Chung Pediatric Renovascular 2017 · Percutaneous transluminal angioplasty 2008

Cerebrovascular follow-up must be integrated into routine FMD care rather than delegated only after a neurologic event. Cohort data linking FMD with cerebrovascular dissection, the enrichment of FMD among spontaneous cervical or intracranial artery dissection patients, and the practical cerebrovascular FMD literature all support a low threshold for reassessment when neurologic symptoms arise. The surgeon’s role is to recognize when vascular symptoms outside the renal bed are part of the same systemic disorder. Fibromuscular Dysplasia Cerebrovascular 2026 · Fibromuscular Dysplasia Spontaneous 2025 · Cerebrovascular Fibromuscular Dysplasia 2023

Developmental renal and aortic disorders need lifelong framing. Pediatric midaortic syndrome and renovascular hypertension cohorts, adult midaortic syndrome experience, and congenital SVAS registry follow-up all show why early technical success must be paired with long-term surveillance for restenosis, reintervention, and late outcomes. These disorders are best managed in programs that can coordinate vascular, renal, cardiac, pediatric, and adult-transition expertise when the anatomy or age of presentation demands it. Long-term outcomes surgical 2024 · Long-term Outcomes After 2024 · Kim Pediatric MAS 2021 · Chung Pediatric Renovascular 2017

The evidence boundaries should be stated plainly in conference and in the chart. Society statements and international consensus documents provide the organizing framework; registries, observational cohorts, imaging cohorts, and genetic studies supply much of the disease-specific knowledge; randomized trials are limited for many practical decisions. That does not make care arbitrary, but it does require transparent counseling, careful documentation of why intervention was chosen, and humility when applying referral-center outcomes to patients outside those settings. Gornik FMD International 2019 · Olin AHA FMD 2014 · Persu European FMD 2014 · Olin US FMD 2012